Search Results 501-510 of 17436 for dyslipidemia

  1. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

  2. Clinical trials - Gastroenterology and Hepatology

    The primary purpose of this study is to create a prospective registry of patients with pouch-related conditions to allow for longitudinal assessment of ...

  3. Gastroenterology and Hepatology - Clinical trials

    The primary purpose of this study is to select and validate candidate methylated DNA markers (MDMs) (individually and in combined panels) for the detection ...

  4. A Study to Identify Genetic Risk Determinants in Families with High Penetrance Type 1 Diabetes - Mayo Clinic

    The purpose of this study is to identify novel genetic variants that predispose to Type 1 Diabetes. Participation eligibility. Participant eligibility includes ...

  5. Meet The Faculty - Cardiovascular Diseases Fellowship (Florida) - Mayo Clinic College of Medicine & Science

    Department and faculty for the Cardiovascular Diseases Fellowship at Mayo Clinic School of Graduate Medical Education in Jacksonville, Florida.

  6. Nosebleeds - Mayo Clinic

    They tend to be more common in children younger than 10 and adults older than 35. Nosebleeds also are called epistaxes (ep-ih-STAK-seez). Nosebleeds may cause ...

  7. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis - Mayo Clinic

    This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition ...

  8. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    About this study. The purpose of this study is to assess the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive ...

  9. Mayo Clinic Minute: Success in reducing heart disease deaths, except for young women Video Audio Sharonne N. Hayes, M.D. Car

    "There is a pretty strong burden of risk factors in those individuals. And often, if we're talking about treatment bias, risk factors that aren't ...

  10. Nutrition and healthy eating Healthy diets - Mayo Clinic

    You can master healthy eating by learning how to plan meals and shop smart, and by practicing healthy-cooking techniques.